CM
CoFlo Medical develops devices that address the injectability bottleneck for high-dose, viscous drug formulations. Utilizing core annular flow technology, their systems enable the delivery of these challenging formulations. This technology unlocks new possibilities for drug development and administration of concentrated biologics.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- CoFlo Medical develops devices that utilize core annular flow technology to address the injectability limitations of high-dose, viscous drug formulations. Their technology enables the delivery of these complex formulations, removing a significant bottleneck in drug development and administration. This specialized delivery system unlocks the potential for new therapeutic options requiring high-concentration subcutaneous injections.